Filing Details
- Accession Number:
- 0001209191-21-006446
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-01 16:30:51
- Reporting Period:
- 2021-01-28
- Accepted Time:
- 2021-02-01 16:30:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1693011 | Inozyme Pharma Inc. | INZY | () | G7 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1388325 | A/S Holdings Novo | Tuborg Havnevej 19 Hellerup G7 2900 | No | No | Yes | No |
Transaction Summary
| Sold: | 375,000 shares | Avg. Price: $21.00 | Total Value: $7,875,000.00 |
| Number of Shares After Transactions: | 2,194,379 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-01-28 | 375,000 | $21.00 | 2,194,379 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The securities were sold as a block sale broker transaction.
Billionaire Hedge Funds
